|Bid||40.35 x 800|
|Ask||40.38 x 800|
|Day's Range||39.83 - 40.45|
|52 Week Range||34.29 - 46.10|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||39.45|
|Forward Dividend & Yield||0.75 (1.86%)|
|Ex-Dividend Date||Apr 05, 2021|
|1y Target Est||49.50|
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce that its wireless, wearable LEAF Patient Monitoring System has monitored more than 60,000 patients with over 7 million hours of use, helping to reduce the economic and human costs of pressure injuries.
Smith & Nephew (LON:SN.) has had a rough three months with its share price down 14%. We, however decided to study the...
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic